• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内(14C)-丙烯酸-2-乙基己酯放射性的分布与消除

Distribution and elimination of (14C)-2-ethylhexyl acrylate radioactivity in rats.

作者信息

Gut I, Vodicka P, Cikrt M, Sapota A, Kavan I

机构信息

Institute of Hygiene and Epidemiology, Praha, Czechoslovakia.

出版信息

Arch Toxicol. 1988;62(5):346-50. doi: 10.1007/BF00293621.

DOI:10.1007/BF00293621
PMID:3149462
Abstract

The fate of (14C)-2-ethylhexyl acrylate was studied in adult male Wistar rats given an intravenous (i.v.) or intraperitoneal (i.p.) injection of 10 mg/kg (0.054 mmol/kg). The elimination of radioactivity from blood was bi-exponential, irrespective of the route of (14C)-2-EHA administration or the age (weight) of the rats. The first phase half-lives after i.v. and i.p. administration in 4-month-old rats were 30 and 60 min, in 7-month-old rats 115 and 130 min, respectively. The corresponding values for the slow-phase were 5 and 6 h, and 14 and 14 h. Elimination of the radioactivity from tissues followed a pattern similar to that seen for blood. More than half of the administered radioactivity was exhaled as carbon dioxide. Exhalation of unchanged (14C)-2-EHA accounted for only 0.05% (i.v.) or 0.3% (i.p.) of the initial dose of radioactivity. The radioactivity excreted in the urine within the first 24 h post-treatment accounted for 7% (i.p.) or 14% (i.v.) of the initial dose, and only 2% was excreted as thioethers.

摘要

在成年雄性Wistar大鼠中,通过静脉注射(i.v.)或腹腔注射(i.p.)给予10 mg/kg(0.054 mmol/kg)的(14C)-丙烯酸2-乙基己酯,研究其命运。无论(14C)-2-EHA的给药途径或大鼠的年龄(体重)如何,血液中放射性的消除都是双指数的。在4个月大的大鼠中,静脉注射和腹腔注射后的第一阶段半衰期分别为30分钟和60分钟,在7个月大的大鼠中分别为115分钟和130分钟。慢相的相应值分别为5小时和6小时,以及14小时和14小时。组织中放射性的消除模式与血液中的相似。超过一半的给药放射性以二氧化碳形式呼出。未变化的(14C)-2-EHA的呼出仅占初始放射性剂量的0.05%(静脉注射)或0.3%(腹腔注射)。治疗后24小时内尿液中排出的放射性占初始剂量的7%(腹腔注射)或14%(静脉注射),只有2%以硫醚形式排出。

相似文献

1
Distribution and elimination of (14C)-2-ethylhexyl acrylate radioactivity in rats.大鼠体内(14C)-丙烯酸-2-乙基己酯放射性的分布与消除
Arch Toxicol. 1988;62(5):346-50. doi: 10.1007/BF00293621.
2
The disposition of [2,3-14C]-methyl and [2,3-14C]-2-ethylhexyl acrylate in male Wistar albino rats.[2,3-14C]-甲基丙烯酸甲酯和[2,3-14C]-2-乙基己酯在雄性Wistar白化大鼠体内的处置情况。
Arch Toxicol. 1988;62(2-3):181-4. doi: 10.1007/BF00570137.
3
Biliary excretion and organ distribution of 14C radioactivity after 14C-2-ethylhexyl acrylate administration in rats.大鼠给予14C-丙烯酸-2-乙基己酯后14C放射性的胆汁排泄及器官分布
J Hyg Epidemiol Microbiol Immunol. 1986;30(4):365-70.
4
The dynamics of distribution and excretion of butyl-(2,3-14C)-acrylate in male Wistar albino rats.丁基 -(2,3 - 14C)- 丙烯酸酯在雄性Wistar白化大鼠体内的分布与排泄动态
Pol J Occup Med Environ Health. 1991;4(1):55-66.
5
Distribution of 2-ethylhexanoic acid in mice and rats after an intraperitoneal injection.腹腔注射后2-乙基己酸在小鼠和大鼠体内的分布。
Pharmacol Toxicol. 1991 Jan;68(1):57-9. doi: 10.1111/j.1600-0773.1991.tb01208.x.
6
Disposition of [14C]methyl bromide in Fischer-344 rats after oral or intraperitoneal administration.
Toxicology. 1984 Sep 14;32(3):187-96. doi: 10.1016/0300-483x(84)90073-8.
7
Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat.给大鼠单次静脉注射或口服[14C]葡萄糖胺后放射性的吸收、分布和排泄。
Pharmatherapeutica. 1984;3(8):538-50.
8
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
9
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.硫酸氨基葡萄糖的吸收、分布、代谢及排泄。综述
Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105.
10
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.4-乙酰氨基苯乙酸的药代动力学。首次通讯:单次给予14C标记化合物后在小鼠、大鼠、狗和猴体内的吸收、分布、代谢及排泄情况
Arzneimittelforschung. 1990 Jul;40(7):800-5.

本文引用的文献

1
Identification or urinary mercapturic acids formed from acrylate, methacrylate and crotonate in the rat.
Xenobiotica. 1981 Apr;11(4):241-7. doi: 10.3109/00498258109045298.
2
Potentiation of acrylate ester toxicity by prior treatment with the carboxylesterase inhibitor triorthotolyl phosphate (TOTP).通过先用羧酸酯酶抑制剂三邻甲苯基磷酸酯(TOTP)进行预处理来增强丙烯酸酯的毒性。
Toxicol Appl Pharmacol. 1981 Feb;57(2):208-19. doi: 10.1016/0041-008x(81)90281-7.
3
Metabolism of acrylate esters in rat tissue homogenates.大鼠组织匀浆中丙烯酸酯的代谢
Fundam Appl Toxicol. 1981 Nov-Dec;1(6):410-4. doi: 10.1016/s0272-0590(81)80018-8.
4
Metabolism of methyl methacrylate: evidence for metabolism by the valine pathway of catabolism in rat and in man.甲基丙烯酸甲酯的代谢:大鼠和人体中通过缬氨酸分解代谢途径进行代谢的证据。
Xenobiotica. 1982 Dec;12(12):821-9. doi: 10.3109/00498258209038954.
5
Pharmacokinetics of acrylamide in Fisher-344 rats.丙烯酰胺在费希尔344大鼠体内的药代动力学
Toxicol Appl Pharmacol. 1982 Mar 30;63(1):36-44. doi: 10.1016/0041-008x(82)90024-2.
6
Acrylonitrile metabolism in the rat.
Arch Toxicol Suppl. 1980;4:322-4. doi: 10.1007/978-3-642-67729-8_66.
7
Biochemical studies on acrylamide, a neurotoxic agent.对神经毒性剂丙烯酰胺的生化研究。
Biochem Pharmacol. 1970 Sep;19(9):2591-604. doi: 10.1016/0006-2952(70)90009-2.
8
Metabolism and pharmacokinetics of vinyl acetate.
Arch Toxicol. 1985 Aug;57(3):191-5. doi: 10.1007/BF00290886.
9
Hydrolysis of several glycol ether acetates and acrylate esters by nasal mucosal carboxylesterase in vitro.鼻腔黏膜羧酸酯酶对几种乙二醇醚醋酸酯和丙烯酸酯的体外水解作用。
Fundam Appl Toxicol. 1985 Apr;5(2):399-404. doi: 10.1016/0272-0590(85)90088-0.
10
Biliary excretion and organ distribution of 14C radioactivity after 14C-2-ethylhexyl acrylate administration in rats.大鼠给予14C-丙烯酸-2-乙基己酯后14C放射性的胆汁排泄及器官分布
J Hyg Epidemiol Microbiol Immunol. 1986;30(4):365-70.